慢性疾病潜在紊乱的病理机制。
Pathomechanisms of Disturbances Underlying Chronic Disorders.
作者信息
Formanowicz Dorota
机构信息
Department of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, Rokietnicka 8, 60-806 Poznań, Poland.
出版信息
Biomedicines. 2024 Jan 9;12(1):131. doi: 10.3390/biomedicines12010131.
Abstract
Chronic disorders' complexity poses enormous challenges to our understanding of such disorders [...].
摘要
慢性疾病的复杂性给我们对这类疾病的理解带来了巨大挑战[……]。
相似文献
1
Pathomechanisms of Disturbances Underlying Chronic Disorders.慢性疾病潜在紊乱的病理机制。
Biomedicines. 2024 Jan 9;12(1):131. doi: 10.3390/biomedicines12010131.
2
[Identification of factors associated with low access to psychiatric care. Concerning 516 psychiatric assessments carried out in the framework of the local medical committee of Martinique].[确定与精神科护理可及性低相关的因素。关于在马提尼克岛地方医疗委员会框架内进行的516例精神科评估]
Encephale. 2023 Aug;49(4):384-392. doi: 10.1016/j.encep.2022.03.006. Epub 2022 Sep 13.
3
Engaging Stakeholders to Optimize Sleep Disorders' Management in the U.S. Military: A Qualitative Analysis.参与方共同参与，优化美国军队中的睡眠障碍管理：定性分析。
Mil Med. 2022 Jul 1;187(7-8):e941-e947. doi: 10.1093/milmed/usab341.
4
Urine Metabolite Analysis to Identify Pathomechanisms of Long COVID: A Pilot Study.尿液代谢物分析以确定长新冠的发病机制：一项初步研究。
Int J Tryptophan Res. 2023 Dec 22;16:11786469231220781. doi: 10.1177/11786469231220781. eCollection 2023.
5
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review.食欲素与α-突触核蛋白病中的睡眠障碍：系统综述。
Curr Neurol Neurosci Rep. 2024 Sep;24(9):389-412. doi: 10.1007/s11910-024-01359-6. Epub 2024 Jul 20.
6
[Pathomechanisms in chronic obstructive pulmonary disease (COPD)].[慢性阻塞性肺疾病（COPD）的发病机制]
Med Klin (Munich). 2006 Dec 15;101(12):951-6. doi: 10.1007/s00063-006-1126-5.
7
Digenic Inheritance in Rare Disorders and Mitochondrial Disease-Crossing the Frontier to a More Comprehensive Understanding of Etiology.双基因遗传在罕见疾病和线粒体疾病中的作用——跨越前沿，更全面地了解病因。
Int J Mol Sci. 2024 Apr 23;25(9):4602. doi: 10.3390/ijms25094602.
8
Identifying non-communicable disease multimorbidity patterns and associated factors: a latent class analysis approach.识别非传染性疾病多重疾病模式和相关因素：一种潜在类别分析方法。
BMJ Open. 2022 Jul 12;12(7):e053981. doi: 10.1136/bmjopen-2021-053981.
9
Cognition in mood disorders.情绪障碍中的认知
BJPsych Open. 2020 Dec 14;7(1):e16. doi: 10.1192/bjo.2020.149.
10
Evaluation of international guidance for the community treatment of 'personality disorders': A systematic review.评估国际“人格障碍”社区治疗指南：系统综述。
PLoS One. 2023 Mar 13;18(3):e0264239. doi: 10.1371/journal.pone.0264239. eCollection 2023.
引用本文的文献
1
Plant-Derived as Alternatives to Animal-Derived Bioactive Peptides: A Review of the Preparation, Bioactivities, Structure-Activity Relationships, and Applications in Chronic Diseases.植物源生物活性肽替代动物源生物活性肽：制备、生物活性、构效关系及在慢性病中应用的综述。
Nutrients. 2024 Sep 27;16(19):3277. doi: 10.3390/nu16193277.
本文引用的文献
1
Rational design of microRNA-responsive switch for programmable translational control in mammalian cells.理性设计 microRNA 响应开关用于哺乳动物细胞中可编程的翻译控制。
Nat Commun. 2023 Nov 8;14(1):7193. doi: 10.1038/s41467-023-43065-w.
2
The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease.微小RNA在导致慢性肾脏病的肾纤维化中的作用
Biomedicines. 2023 Aug 23;11(9):2358. doi: 10.3390/biomedicines11092358.
3
Current Management and Future Perspectives in the Treatment of Lp(a) with a Focus on the Prevention of Cardiovascular Diseases.脂蛋白(a)治疗的当前管理及未来展望：聚焦心血管疾病的预防
Pharmaceuticals (Basel). 2023 Jun 23;16(7):919. doi: 10.3390/ph16070919.
4
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.miRNAs：癌症的潜在生物标志物和治疗靶点。
Genes (Basel). 2023 Jun 29;14(7):1375. doi: 10.3390/genes14071375.
5
Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease.代谢综合征概述及新认识：2 型糖尿病和心脑血管疾病发展中的危险因素和新兴变量。
Medicina (Kaunas). 2023 Mar 13;59(3):561. doi: 10.3390/medicina59030561.
6
Chronic Kidney Disease as a Cardiovascular Disorder-Tonometry Data Analyses.慢性肾脏病作为一种心血管疾病-眼压测量数据分析。
Int J Environ Res Public Health. 2022 Sep 28;19(19):12339. doi: 10.3390/ijerph191912339.
7
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄：欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
8
The Mutual Contribution of 3-NT, IL-18, Albumin, and Phosphate Foreshadows Death of Hemodialyzed Patients in a 2-Year Follow-Up.3-硝基酪氨酸、白细胞介素-18、白蛋白和磷酸盐的共同作用预示着血液透析患者在两年随访中的死亡。
Antioxidants (Basel). 2022 Feb 11;11(2):355. doi: 10.3390/antiox11020355.
9
Multi-Target Approaches in Metabolic Syndrome.代谢综合征的多靶点治疗方法
Front Pharmacol. 2021 Mar 12;11:554961. doi: 10.3389/fphar.2020.554961. eCollection 2020.
10
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.肿瘤抑制因子 miR-34a 的下调通过上调 MET 癌基因和调节肿瘤免疫逃逸促进头颈部癌症的发生。
J Exp Clin Cancer Res. 2021 Feb 17;40(1):70. doi: 10.1186/s13046-021-01865-2.
Zotero 插件